Andere talen Piramal Pharma Limited Bombay S.E.

Aandelen

PPLPHARMA

INE0DK501011

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:51 16-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
152,8 ^INR	+0,46%		-1,86%	+10,09%

14/05	PIRAMAL PHARMA LIMITED : Jefferies & Co. bevestigt koopadvies	ZM
13/05	Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Piramal Pharma Limited Discloses the Penalties in Respect of Which Orders Received by the Company Pertaining to the Company's Plant Located At Pithampur, Madhya Pradesh	08/07
Piramal Pharma Limited Announces Results for Q4 and FY2024	10/05
Piramal Pharma Limited Announces Resignation of Nathalie Leitch as Non-Executive, Non-Independent Director	10/05
Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024	10/05
Piramal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	10/05
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10/05
Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department	27/04
Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996	19/04
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility	18/04
Los mercados de India cierran a la baja en medio de sentimientos tibios de los inversores -- Market Talk	12/04
Piramal Pharma Forays into Men Grooming Products	10/04
Piramal Pharma Limited Announces the Launch of BOHEM Product Range	10/04
Piramal Pharma Turns to Profit in Fiscal Q3	31/01
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024	30/01
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	30/01
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND	18/12
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland	18/12
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China	27/11
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection	09/11
Piramal Pharma Swings to Profit in Fiscal Q2	30-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Piramal Pharma Limited Bombay S.E.

Aandelen

PPLPHARMA

INE0DK501011

Andere talen

Filters